EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.118, no.8, pp.537-543, 2010 (SCI-Expanded)
Context: The presence and the importance of FasL (FasL, APO-1L/CD95L) in papillary microcarcinoma lesions which are smaller than 1.5 cm of the thyroid is unclear.